PH12019502629A1 - Liquid composition including alginic acid or pharmaceutically acceptable salt thereof and colloidal polysaccharide - Google Patents

Liquid composition including alginic acid or pharmaceutically acceptable salt thereof and colloidal polysaccharide

Info

Publication number
PH12019502629A1
PH12019502629A1 PH12019502629A PH12019502629A PH12019502629A1 PH 12019502629 A1 PH12019502629 A1 PH 12019502629A1 PH 12019502629 A PH12019502629 A PH 12019502629A PH 12019502629 A PH12019502629 A PH 12019502629A PH 12019502629 A1 PH12019502629 A1 PH 12019502629A1
Authority
PH
Philippines
Prior art keywords
endoscopic
liquid
pharmaceutically acceptable
acceptable salt
alginic acid
Prior art date
Application number
PH12019502629A
Inventor
Eun Jung Lee
Cheol Woo Lee
Original Assignee
Korea Mcnultys Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Mcnultys Co Ltd filed Critical Korea Mcnultys Co Ltd
Publication of PH12019502629A1 publication Critical patent/PH12019502629A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The present invention relates to a liquid-phase composition containing alginic acid or a pharmaceutically acceptable salt thereof and a colloidal polysaccharide, the composition being suitable as a medical biomaterial for tissue restoration used to elevate mucosal tissue of stomach, bowels, or the like when the mucosal tissue is subjected to endoscopic excision, and more specifically, to a liquid-phase composition, which is a medical pharmaceutical composition to be injected into the submucosal layer in endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD), wherein the liquid-phase composition contains alginic acid having a weight average molecular weight of 100,000 to less than 200,000 or a pharmaceutically acceptable salt thereof, and a colloidal polysaccharide. According to the present invention, the liquid-phase composition can be effectively used as a local submucosal injection agent which superbly sustains injection-induced elevation of mucous membranes during endoscopic mucosal resection or endoscopic submucosal dissection.
PH12019502629A 2017-06-12 2019-11-22 Liquid composition including alginic acid or pharmaceutically acceptable salt thereof and colloidal polysaccharide PH12019502629A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020170073128A KR101884467B1 (en) 2017-06-12 2017-06-12 Liquid composition comprising alginate or a pharmaceutically acceptable salt thereof, and polysaccharide colloids
PCT/KR2018/006617 WO2018230915A1 (en) 2017-06-12 2018-06-11 Liquid-phase composition containing alginic acid or pharmaceutically acceptable salt thereof and colloidal polysaccharide

Publications (1)

Publication Number Publication Date
PH12019502629A1 true PH12019502629A1 (en) 2020-06-08

Family

ID=63251399

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12019502629A PH12019502629A1 (en) 2017-06-12 2019-11-22 Liquid composition including alginic acid or pharmaceutically acceptable salt thereof and colloidal polysaccharide

Country Status (7)

Country Link
US (1) US11071807B2 (en)
EP (1) EP3639862A4 (en)
JP (1) JP6901657B2 (en)
KR (1) KR101884467B1 (en)
CN (1) CN110740761B (en)
PH (1) PH12019502629A1 (en)
WO (1) WO2018230915A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11679076B2 (en) * 2020-08-06 2023-06-20 T-ACE Medical Co., Ltd. Composition for submucosal injection and preparation method thereof
CN114377214A (en) * 2022-03-01 2022-04-22 南京工业大学 Injectable sodium alginate hydrogel for assisting EMR or ESD operation
WO2023201575A1 (en) * 2022-04-20 2023-10-26 江苏扬子江医疗科技股份有限公司 Injection type hydrogel, preparation method therefor, and use of injection type hydrogel as submucosal injection for endoscope adjuvant treatment

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005039672A1 (en) * 2003-10-23 2007-02-22 株式会社信州Tlo Method of thickening thickening composition and needle device
US20050208134A1 (en) * 2004-02-25 2005-09-22 Shlomo Magdassi Biocompatible polymeric beads and use thereof
MX2009001608A (en) * 2006-08-24 2009-02-23 Unilever Nv Liquid satiety enhancing composition.
JP5613567B2 (en) * 2007-11-29 2014-10-22 ジェンザイム・コーポレーション Endoscopic mucosal resection using purified reverse thermosensitive polymer
WO2013077357A1 (en) 2011-11-25 2013-05-30 日本製薬株式会社 Submucosal cushioning agent
KR101436406B1 (en) 2011-12-29 2014-09-02 주식회사 안랩 Client, server, system and method for updating data based on peer to peer
CN103071181B (en) * 2013-02-01 2015-04-29 刘昌桂 Hydrogel as well as preparation method and purpose of hydrogel
JP6099044B2 (en) * 2013-03-26 2017-03-22 国立大学法人 大分大学 Medical composition
EP3013270A4 (en) * 2013-06-26 2017-02-22 Vicut Medical Devices Ltd. Device, kit and method for prolonged lifting of a tissue during endoscopic procedure
KR102077158B1 (en) 2013-07-10 2020-02-13 삼성전자 주식회사 Apparatus and method for operating message function which is associated memo function
KR101531091B1 (en) 2013-07-19 2015-06-24 유재원 Injectable agent for tissue repair treatment comprising the substance polymerizing hydrophobic biocompatible polymer and hydrophilic biocompatible polymer
US20150099928A1 (en) * 2013-10-07 2015-04-09 Boston Scientific Scimed, Inc. Injectable compositions
ITMI20131927A1 (en) * 2013-11-20 2015-05-21 Cosmo Technologies Ltd EMULSIONS OR MICROEMULSIONS FOR USE IN ENDOSCOPIC MUCOSAL RESECTIONING AND / OR ENDOSCOPIC SUBMUCOSAL DISSECTION. EMULSIONS OR MICROEMULSIONS FOR USE IN ENDOSCOPIC MUCOSAL RESECTION AND / OR ENDOSCOPIC SUBMUCOSAL DISSECTION
ITMI20131924A1 (en) * 2013-11-20 2015-05-21 Cosmo Technologies Ltd EMULSIONS OR MICROEMULSIONS FOR USE IN ENDOSCOPIC AND MUCOSAL RESECTIONING AND / OR
KR20160033897A (en) * 2014-09-19 2016-03-29 주식회사 덱스레보 Composition for tissue repair treatment and methods of manufacturing the same
KR20160043547A (en) 2014-10-13 2016-04-22 (주)에코팜 Natural disinfection for horticultural crops produced thereby and method of manufacturing pesticides and natural disinfection and pesticides
US10179190B2 (en) * 2015-05-29 2019-01-15 Boston Scientific Scimed, Inc. Compositions and methods for treatment of tissue
CN105251048A (en) * 2015-10-16 2016-01-20 山东福瑞达医药集团公司 Injectable cartilage tissue protection and repair material containing xanthan gum

Also Published As

Publication number Publication date
JP2020523059A (en) 2020-08-06
JP6901657B2 (en) 2021-07-14
KR101884467B1 (en) 2018-08-02
EP3639862A1 (en) 2020-04-22
US11071807B2 (en) 2021-07-27
CN110740761B (en) 2022-10-25
US20200114047A1 (en) 2020-04-16
CN110740761A (en) 2020-01-31
EP3639862A4 (en) 2021-04-07
WO2018230915A1 (en) 2018-12-20

Similar Documents

Publication Publication Date Title
PH12019502629A1 (en) Liquid composition including alginic acid or pharmaceutically acceptable salt thereof and colloidal polysaccharide
Herrero et al. Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett's esophagus longer than 10 cm
JP2016514108A5 (en)
JP2017505761A5 (en)
JP2001192336A5 (en)
EP2349367A4 (en) Modified silk films containing glycerol
JP7203428B2 (en) ECM hydrogel for treating esophageal inflammation
AR068302A1 (en) PEPTIDES FOR VACCINES FOR CANCERS EXPRESSING ANTIGENS ASSOCIATED WITH TUMORS
JP6284163B2 (en) Pharmaceutical composition for wound protection, hemostasis or prevention of adhesions in the gastrointestinal tract
JP2016518442A5 (en)
AU2015287920A8 (en) Micronized Wharton's Jelly
ZA202202410B (en) Rna particles comprising polysarcosine
JP2015514778A5 (en)
SV2011003907A (en) ANTIMICROBIAL COMPOSITIONS
RU2016137292A (en) FGF-18 COMPOUND DIAGRAM
CN102657650A (en) Esomeprazole sodium lyophilized powder composition for injection and preparation method thereof
MD3905G2 (en) Remedy of durable action in the form of gel for treatment of parodentium affections (variants)
KR102169251B1 (en) A pharmaceutical composition
RU2007129571A (en) COMPOSITIONS BASED ON SALTS OF HYALURONIC ACID FOR THE TREATMENT OF EPITELIAL INJURIES
Bartova et al. Endoscopic treatment of a giant pedunculated angiolipofibroma of the distal duodenum
Harati et al. THE USE OF PRONTOSAN® WOUND GEL X IN PARTIAL AND FULL THICKNESS BURNS REQUIRING SPLIT THICKNESS SKIN GRAFTS-AN INTERIM ANALYSIS (174)
TH1901007727A (en) Liquid composition that includes algenic acid or the pharmaceutically recognized salt of that and very small polysaccharides.
Xu et al. Mo2047 The Effectiveness of the Triamcinolone-Loaded Thermogel System to Prevent Esophageal Stricture After Endoscopic Submucosal Dissection in a Porcine Model
Parra-Blanco et al. PTH-059 Circumferential esd for squamous oesophageal neoplasia using the double tunnel technique: an organ preserving procedure
Fujino et al. Sa1419 Usefulness of a New Sphincterotome for the Endoscopic Submucosal Dissection of Colorectal Neoplasms